Drug details:
Molecular formula: C₁₈H₂₂O₅

Standard name: 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol

Synonyms:

2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol 2-methoxy-5-(3,4,5-trimethoxyphenethyl)phenol 2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-ethyl]-phenol Phenol, 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]- Erianin? 2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol Dendrobium chrysotoxum B817373-K388, same as Erianin2-methoxy-5-(3,4,5-trimethoxyphenethyl)phenol 2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-ethyl]-phenol

Curated SMILES: COC1=C(C=C(C=C1)CCC2=CC(=C(C(=C2)OC)OC)OC)O

Evidence for compound's anti-virulence activity:

Staphylococcus
Related VF: FnBPs (Fibronectin binding proteins)
Target: SrtA
Drug effect: Inhibits SrtA-mediated S. aureus adhesion to fibronectin and biofilm formation.
Max phase: Preclinical (in vivo)
Publication:
Ouyang P, et al., 2018. Erianin against Staphylococcus aureus Infection via Inhibiting Sortase A. Toxins (Basel) 10(10):385.